文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

NLRP3炎症小体激活促进中性粒细胞胞外诱捕网形成并影响脓毒症预后的机制

[The mechanism by which NLRP3 inflammasome activation promotes the formation of neutrophil extracellular traps and affects the prognosis of sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2026-01-01
一句话结论小鼠脓毒症模型中,NLRP3缺失可抑制NETs形成、减轻炎症和器官损伤、增强细菌清除,但7天生存率反而更低(16.7% vs 55.6%)。

该研究将野生型(WT)与NLRP3敲除(NLRP3-/-)小鼠随机分为假手术组和盲肠结扎穿孔(CLP)组,每组6只,观察肝脏和肺组织病理、血细胞因子、Cit-H3、MPO-DNA复合物、肺组织PAD4和Cit-H3蛋白表达、外周血和腹腔灌洗液菌落计数及7天生存率。CLP术后,WT与NLRP3-/-小鼠均出现生存率下降、炎症因子升高、肝肾肺损伤加重、细菌负荷增加及NETs标志物升高。与WT-CLP组相比,NLRP3-/--CLP组促炎因子IL-1β、IL-6、TNF-α降低,抗炎因子IL-10升高,肝肺损伤评分减轻,外周血和腹腔灌洗液菌落计数减少,肺组织PAD4和Cit-H3蛋白表达及血清Cit-H3、MPO-DNA复合物降低,但7天生存率更低(16.7% vs 55.6%,P<0.05)。作者认为NLRP3炎症小体可能通过正向调控NETs形成参与炎症放大和器官损伤,NLRP3-NET轴可能是脓毒症的潜在干预靶点。

要点

  • NLRP3-/--CLP组7天生存率16.7%,低于WT-CLP组的55.6%(Log-rank χ²=4.35,P<0.05)。
  • NLRP3-/--CLP组较WT-CLP组促炎因子降低:IL-1β 136.30±56.16 vs 243.50±55.29 ng/L,IL-6 411.30±114.50 vs 669.70±222.60 ng/L,TNF-α 672.80±16.43 vs 717.30±30.16 ng/L。
  • NLRP3-/--CLP组较WT-CLP组抗炎因子IL-10升高(1111.00±223.20 vs 833.70±154.90 ng/L),肝损伤评分降低(2.50±0.55 vs 3.67±0.52),肺损伤评分降低(2.33±0.52 vs 3.67±0.52)。
  • NLRP3-/--CLP组较WT-CLP组细菌清除改善:外周血菌落计数12.16±7.31 vs 36.00±13.80×10⁵ CFU/L,腹腔灌洗液菌落计数113.33±79.69 vs 277.00±77.23×10⁷ CFU/L。
  • NLRP3-/--CLP组较WT-CLP组NETs标志物降低:血清Cit-H3 132.80±20.68 vs 182.70±13.43 ng/L,MPO-DNA 47.67±34.96 vs 177.20±43.95 ng/L,肺组织PAD4/β-actin 0.17±0.05 vs 0.29±0.05,Cit-H3/β-actin 1.36±0.23 vs 1.96±0.26。

适用人群与场景

  • 野生型(WT)与NLRP3敲除(NLRP3-/-)小鼠,随机分为假手术组和盲肠结扎穿孔(CLP)组,每组6只。

研究设计与关键结果

  • 研究类型:动物实验;样本量:每组6只小鼠,共4组;人群:WT与NLRP3-/-小鼠;干预:盲肠结扎穿孔(CLP) vs 假手术(Sham);主要终点:术后24小时肝肺组织病理、血细胞因子、Cit-H3、MPO-DNA、肺组织PAD4和Cit-H3蛋白表达、外周血和腹腔灌洗液菌落计数及7天生存率。
  • 与相应Sham组比较,WT和NLRP3-/-小鼠CLP术后生存率均下降,血清IL-1β、IL-6、TNF-α、IL-10均升高,肝肺组织病理损伤加重,外周血和腹腔灌洗液细菌负荷升高,肺组织PAD4和Cit-H3蛋白表达上调,血清Cit-H3和MPO-DNA复合物升高(均P<0.05)。
  • 与WT-CLP组比较,NLRP3-/--CLP组7天生存率更低(16.7% vs 55.6%,Log-rank χ²=4.35,P<0.05)。
  • 与WT-CLP组比较,NLRP3-/--CLP组促炎因子IL-1β、IL-6、TNF-α降低(IL-1β:136.30±56.16 vs 243.50±55.29 ng/L;IL-6:411.30±114.50 vs 669.70±222.60 ng/L;TNF-α:672.80±16.43 vs 717.30±30.16 ng/L),抗炎因子IL-10升高(1111.00±223.20 vs 833.70±154.90 ng/L),肝损伤评分降低(2.50±0.55 vs 3.67±0.52),肺损伤评分降低(2.33±0.52 vs 3.67±0.52),外周血菌落计数减少(12.16±7.31 vs 36.00±13.80×10⁵ CFU/L),腹腔灌洗液菌落计数减少(113.33±79.69 vs 277.00±77.23×10⁷ CFU/L),肺组织PAD4/β-actin降低(

证据类型、等级与局限

  • 证据类型:动物实验(小鼠CLP脓毒症模型);局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为NLRP3炎症小体可能通过正向调控NETs形成参与炎症放大和器官损伤,从而影响脓毒症病程和结局。
  • 作者认为NLRP3缺失可抑制异常NETs形成、减轻炎症反应和器官损伤、增强细菌清除,从而改善脓毒症小鼠预后,提示NLRP3-NET轴可能作为脓毒症的潜在干预靶点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the intrinsic relationship between NOD-like receptor protein 3 (NLRP3) inflammasome activation and neutrophil extracellular traps (NETs) formation, as well as their mechanism of action in the pathological process of sepsis.

METHODS: Wild-type (WT) and NLRP3 knockout (NLRP3-/-) mice were randomly divided into sham operation (Sham) group and cecal ligation and puncture (CLP) group, namely WT-Sham group, NLRP3-/--Sham group, WT-CLP group and NLRP3-/--CLP group, with 6 mice in each group. At 24 hours after operation, hematoxylin-eosin (HE) staining was used to observe histopathological changes in the liver and lung tissues; enzyme linked immunosorbent assay (ELISA) was performed to detect the levels of blood cytokines, citrullinated histone H3 (Cit-H3), and myeloperoxidase-DNA (MPO-DNA) complexes; Western blotting was used to measure the protein expressions of peptidylarginine deiminase 4 (PAD4) and Cit-H3 in lung tissue. Meanwhile, colony counts in peripheral blood and peritoneal lavage fluid (PLF) were determined in each group. The 7-day survival of mice in each group was observed postoperatively.

RESULTS: Compared with the corresponding Sham group, the survival rate of WT and NLRP3-/- mice was decreased after CLP, while the serum levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and interleukin-10 (IL-10) were increased, pathological injury in the liver and lung tissues was aggravated, bacterial burden in peripheral blood and PLF was elevated, protein expressions of PAD4 and Cit-H3 in lung tissue were up-regulated, and serum levels of Cit-H3 and MPO-DNA complexes were increased (all P<0.05). Compared with the WT-CLP group, the NLRP3-/--CLP group showed a lower 7-day survival rate (16.7% vs. 55.6%, Log-rank test: χ 2=4.35, P<0.05), the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α were decreased [IL-1β (ng/L): 136.30±56.16 vs. 243.50±55.29, IL-6 (ng/L): 411.30±114.50 vs. 669.70±222.60, TNF-α (ng/L): 672.80±16.43 vs. 717.30±30.16], whereas the anti-inflammatory cytokine IL-10 was increased (ng/L: 1 111.00±223.20 vs. 833.70±154.90), pathological injury in the liver and lung tissues was alleviated (liver injury score: 2.50±0.55 vs. 3.67±0.52, lung injury score: 2.33±0.52 vs. 3.67±0.52), bacterial clearance was markedly improved [peripheral blood colony count (×105 CFU/L): 12.16±7.31 vs. 36.00±13.80, PLF colony count (×107 CFU/L): 113.33±79.69 vs. 277.00±77.23], protein expressions of PAD4 and Cit-H3 in lung tissue were reduced (PAD4/β-actin: 0.17±0.05 vs. 0.29±0.05, Cit-H3/β-actin: 1.36±0.23 vs. 1.96±0.26), and serum levels of Cit-H3 and MPO-DNA complexes were also decreased [Cit-H3 (ng/L): 132.80±20.68 vs. 182.70±13.43, MPO-DNA (ng/L): 47.67±34.96 vs. 177.20±43.95], all differences were statistically significant (all P<0.05).

CONCLUSIONS: The NLRP3 inflammasome may participate in inflammatory amplification and organ injury by positively regulating NET formation, thereby influencing the course and outcome of sepsis. NLRP3 deficiency can suppress aberrant NET formation, alleviate inflammatory responses and organ damage, enhance bacterial clearance, and thus improve the prognosis of septic mice, suggesting that the NLRP3-NET axis may serve as a potential intervention target for sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wang C, Wang C, Zhang W, et al. [The mechanism by which NLRP3 inflammasome activation promotes the formation of neutrophil extracellular traps and affects the prognosis of sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2026. PMID: 42281536. doi:10.3760/cma.j.cn121430-20250626-00352

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。